CAS: 1131626-47-5
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | Gamitrinib TPP hexafluorophosphate REF: IN-DA01EO4XCAS: 1131626-47-5 | 99% | To inquire | Tue 10 Dec 24 |
 | Gamitrinib TPP hexafluorophosphate REF: TM-T11356CAS: 1131626-47-5 | 98.52% - 98.52% | To inquire | Tue 10 Dec 24 |
 | Gamitrinib-TPP REF: 3D-GVB62647CAS: 1131626-47-5 | Min. 95% | To inquire | Fri 17 Jan 25 |
Gamitrinib TPP hexafluorophosphate
CAS:1131626-47-5
Formula:
C52H65F6N3O8P2
Purity:
99%
Molecular weight:
1036.0257
Ref: IN-DA01EO4X
| 1mg | 619.00 € |
Estimated delivery in United States, on Tuesday 10 Dec 2024
Gamitrinib TPP hexafluorophosphate
CAS:1131626-47-5
Gamitrinib TPP hexafluorophosphate is a mitochondrial-targeted HSP90 inhibitor with anticancer activity that can be used …
Formula:
C52H65F6N3O8P2
Purity:
98.52% - 98.52%
Color and Shape:
Solid
Molecular weight:
1036.03
Ref: TM-T11356
| 1mg | 545.00 € |
Estimated delivery in United States, on Tuesday 10 Dec 2024
Gamitrinib-TPP
CAS:1131626-47-5
Gamitrinib-TPP is a synthetic drug that was developed to target cancer cells. It has been …
Formula:
C53H67F6N3O8P2
Purity:
Min. 95%
Molecular weight:
1,050.05 g/mol
Ref: 3D-GVB62647
| 1mg | To inquire | ||
| 5mg | To inquire | ||
| 10mg | To inquire | ||
| 25mg | To inquire | ||
| 50mg | To inquire |
Estimated delivery in United States, on Friday 17 Jan 2025
